Literature DB >> 2400651

Continuous arteriovenous haemofiltration in the treatment of tumour lysis syndrome.

D Heney1, A Essex-Cater, J T Brocklebank, C C Bailey, I J Lewis.   

Abstract

The management of tumour lysis syndrome remains problematic despite the rigorous use of preventative measures. Continuous arteriovenous haemofiltration (CAVH) is well suited to its use in both the prevention and treatment of metabolic abnormalities and renal insufficiency associated with tumour lysis. We report the successful use of CAVH in the treatment of a patient with tumour lysis syndrome.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2400651     DOI： 10.1007/bf00857665

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  10 in total

1.  Hyperuricemic acute renal failure.

Authors:  C M Kjellstrand; D C Cambell; B von Hartitzsch; T J Buselmeier
Journal:  Arch Intern Med       Date:  1974-03

2.  Transient acute renal failure due to tumor-lysis-induced severe phosphate load in a patient with Burkitt's lymphoma.

Authors:  J Monballyu; P Zachee; R Verberckmoes; M A Boogaerts
Journal:  Clin Nephrol       Date:  1984-07       Impact factor: 0.975

3.  Acute renal failure induced by hyperphosphatemia in acute lymphoblastic leukemia.

Authors:  B S Kaplan; D Hébert; R E Morrell
Journal:  Can Med Assoc J       Date:  1981-02-15       Impact factor: 8.262

4.  Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma.

Authors:  L F Cohen; J E Balow; I T Magrath; D G Poplack; J L Ziegler
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

5.  Studies of the mechanism by which phosphate infusion lowers serum calcium concentration.

Authors:  L A Hebert; J Lemann; J R Petersen; E J Lennon
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

6.  Continuous arteriovenous haemofiltration in the newlyborn with acute renal failure and congenital heart disease.

Authors:  D Heney; J T Brocklebank; N Wilson
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

7.  Hyperphosphatermia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia.

Authors:  E C Cadman; W B Lunberg; J R Bertino
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

8.  Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma.

Authors:  F B Stapleton; D R Strother; S Roy; R J Wyatt; C P McKay; S B Murphy
Journal:  Pediatrics       Date:  1988-12       Impact factor: 7.124

Review 9.  Continuous arteriovenous hemofiltration in children.

Authors:  K V Lieberman
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas.

Authors:  G C Tsokos; J E Balow; R J Spiegel; I T Magrath
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889
  10 in total
  8 in total

1.  The intensive care unit in paediatric oncology.

Authors:  D Heney; I J Lewis; L Lockwood; A T Cohen; C C Bailey
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

Review 2.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

3.  Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.

Authors:  S L Saccente; E C Kohaut; R L Berkow
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 4.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

Review 5.  Continuous arterial-venous diahemofiltration and continuous veno-venous diahemofiltration in infants and children.

Authors:  T E Bunchman; R A Donckerwolcke
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 6.  Tumor lysis syndrome: pathogenesis and management.

Authors:  D P Jones; H Mahmoud; R W Chesney
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

7.  Impact of daytime continuous veno-venous haemofiltration on treatment of paediatric tumour lysis syndrome.

Authors:  Yamei Wang; Jing Lu; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-06-08       Impact factor: 1.671

Review 8.  Tumor lysis syndrome in childhood malignancies.

Authors:  Wing Lum Cheung; Kam Lun Hon; Cheuk Man Fung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2020-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.